title: Rivaroxaban versus enoxaparin after total knee arthroplasty.
authors.forename: Umile Giuseppe
authors.initials: UG
authors.lastname: Longo
authors.forename: Nicola
authors.initials: N
authors.lastname: Maffulli
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Denaro
mesh_terms: D000359:Aftercare; D000925:Anticoagulants / Q000009:adverse effects; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects; D016903:Drug Monitoring; D017984:Enoxaparin / Q000009:adverse effects; D065427:Factor Xa Inhibitors; D006801:Humans; D009025:Morpholines / Q000009:adverse effects*; D018579:Patient Selection; D012307:Risk Factors; D000069552:Rivaroxaban; D013876:Thiophenes / Q000009:adverse effects*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban